Timber Pharmaceuticals Financials

Timber Pharmaceuticals Stock Summary

Timber Pharmaceuticals competes with Salarius Pharmaceuticals, Nutriband, Artelo Biosciences, Curis, and SAB Biotherapeutics. Timber Pharmaceuticals LLC, a clinical-stage biopharmaceutical company, engages in the development and commercialization of treatments for orphan dermatologic diseases. The company was founded in 2019 and is headquartered in Basking Ridge, New Jersey. Timber Pharmaceuticals operates under Biotechnology classification in the United States and is traded on AMEX Exchange. It employs 5 people.

Timber Pharmaceuticals Key Financial Ratios

Timber Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Timber Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Timber Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Timber Pharmaceuticals competition to find correlations between indicators driving Timber Pharmaceuticals's intrinsic value. More Info.Timber Pharmaceuticals is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Timber Pharmaceuticals by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

If you are still planning to invest in Timber Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Timber Pharmaceuticals' history and understand the potential risks before investing.